The vaccine product independently developed by China Animal Husbandry Industry Co., Ltd (CAHIC). is used to prevent feline rhinotracheitis, feline calicivirus disease, and feline panleukopenia. It is formulated with carefully selected locally prevalent viral strains, offering stronger matching capability, higher antigen content, and more effective protection. It is the only vaccine in China that can induce protection against feline panleukopenia just 21 days after the initial vaccination, significantly reducing the immune vulnerability window.